Abstract
Background:
Children’s interstitial lung diseases (chILD) comprise a broad spectrum of diseases. Besides the genetically defined surfactant dysfunction disorders, most entities pathologically involve the alveolar surfactant region, possibly affecting the surfactant proteins SP-B and SP-C. Therefore, our objective was to determine the value of quantitation of SP-B and SP-C levels in bronchoalveolar lavage fluid (BALF) for the diagnosis of chILD.
Methods:
Levels of SP-B and SP-C in BALF from 302 children with chILD and in controls were quantified using western blotting. In a subset, single-nucleotide polymorphisms (SNPs) in the SFTPC promoter were genotyped by direct sequencing.
Results:
While a lack of dimeric SP-B was found only in the sole subject with hereditary SP-B deficiency, low or absent SP-C was observed not only in surfactant dysfunction disorders but also in patients with other diffuse parenchymal lung diseases pathogenetically related to the alveolar surfactant region. Genetic analysis of the SFTPC promoter showed association of a single SNP with SP-C level.
Conclusion:
SP-B levels may be used for screening for SP-B deficiency, while low SP-C levels may point out diseases caused by mutations in TTF1, SFTPC, ABCA3, and likely in other genes involved in surfactant metabolism that remain to be identified. We conclude that measurement of levels of SP-B and SP-C was useful for the differential diagnosis of chILD, and for the precise molecular diagnosis, sequencing of the genes is necessary.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Griese M, Haug M, Brasch F, et al. Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany. Orphanet J Rare Dis 2009;4:26.
Clement A ; ERS Task Force. Task force on chronic interstitial lung disease in immunocompetent children. Eur Respir J 2004;24:686–97.
Kurland G, Deterding RR, Hagood JS, et al.; American Thoracic Society Committee on Childhood Interstitial Lung Disease (chILD) and the chILD Research Network. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med 2013;188:376–94.
Bush A, Anthony G, Barbato A, et al.; ch-ILD collaborators. Research in progress: put the orphanage out of business. Thorax 2013;68:971–3.
Hamvas A. Evaluation and management of inherited disorders of surfactant metabolism. Chin Med J (Engl) 2010;123:2943–7.
Deutsch GH, Young LR, Deterding RR, et al.; Pathology Cooperative Group; ChILD Research Co-operative. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med 2007;176:1120–8.
Nogee LM, de Mello DE, Dehner LP, Colten HR. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993;328:406–10.
Nogee LM, Dunbar AE 3rd, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001;344:573–9.
Weaver TE, Conkright JJ. Function of surfactant proteins B and C. Annu Rev Physiol 2001;63:555–78.
Nogee LM. Genetics of the hydrophobic surfactant proteins. Biochim Biophys Acta 1998;1408:323–33.
Khoor A, Stahlman MT, Gray ME, Whitsett JA. Temporal-spatial distribution of SP-B and SP-C proteins and mRNAs in developing respiratory epithelium of human lung. J Histochem Cytochem 1994;42:1187–99.
Kormann MS, Hasenpusch G, Aneja MK, et al. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat Biotechnol 2011;29:154–7.
Tafel O, Latzin P, Paul K, Winter T, Woischnik M, Griese M. Surfactant proteins SP-B and SP-C and their precursors in bronchoalveolar lavages from children with acute and chronic inflammatory airway disease. BMC Pulm Med 2008;8:6.
Beers MF, Fisher AB. Surfactant protein C: a review of its unique properties and metabolism. Am J Physiol 1992;263:L151–60.
Kröner C, Reu S, Teusch V, et al. Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients. Eur Respir J 2015;46:197–206.
Griese M, Schumacher S, Tredano M, et al. Expression profiles of hydrophobic surfactant proteins in children with diffuse chronic lung disease. Respir Res 2005;6:80.
Tredano M, van Elburg RM, Kaspers AG, et al. Compound SFTPB 1549C–>GAA (121ins2) and 457delC heterozygosity in severe congenital lung disease and surfactant protein B (SP-B) deficiency. Hum Mutat 1999;14:502–9.
Tredano M, Griese M, de Blic J, et al. Analysis of 40 sporadic or familial neonatal and pediatric cases with severe unexplained respiratory distress: relationship to SFTPB. Am J Med Genet A 2003;119A:324–39.
Thouvenin G, Abou Taam R, Flamein F, et al. Characteristics of disorders associated with genetic mutations of surfactant protein C. Arch Dis Child 2010;95:449–54.
Tredano M, Griese M, Brasch F, et al. Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease. Am J Med Genet A 2004;126A:18–26.
Flamein F, Riffault L, Muselet-Charlier C, et al. Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children. Hum Mol Genet 2012;21:765–75.
Kleinlein B, Griese M, Liebisch G, et al. Fatal neonatal respiratory failure in an infant with congenital hypothyroidism due to haploinsufficiency of the NKX2-1 gene: alteration of pulmonary surfactant homeostasis. Arch Dis Child Fetal Neonatal Ed 2011;96:F453–6.
Wambach JA, Yang P, Wegner DJ, et al. Surfactant protein-C promoter variants associated with neonatal respiratory distress syndrome reduce transcription. Pediatr Res 2010;68:216–20.
Schuerman FA, Griese M, Gille JP, Brasch F, Noorduyn LA, van Kaam AH. Surfactant protein B deficiency caused by a novel mutation involving multiple exons of the SP-B gene. Eur J Med Res 2008;13:281–6.
Dunbar AE 3rd, Wert SE, Ikegami M, et al. Prolonged survival in hereditary surfactant protein B (SP-B) deficiency associated with a novel splicing mutation. Pediatr Res 2000;48:275–82.
Ballard PL, Nogee LM, Beers MF, et al. Partial deficiency of surfactant protein B in an infant with chronic lung disease. Pediatrics 1995;96:1046–52.
Akinbi HT, Breslin JS, Ikegami M, et al. Rescue of SP-B knockout mice with a truncated SP-B proprotein. Function of the C-terminal propeptide. J Biol Chem 1997;272:9640–7.
Simonato M, Baritussio A, Pioselli B, et al. Surfactant protein C metabolism in human infants and adult patients by stable isotope tracer and mass spectrometry. Anal Bioanal Chem 2014;406:6225–33.
Simonato M, Baritussio A, Vedovelli L, Lamonica G, Carnielli VP, Cogo PE. Surfactant protein B amount and kinetics in newborn infants: an optimized procedure. J Mass Spectrom 2012;47:1415–9.
Griese M, Dietrich P, Reinhardt D. Pharmacokinetics of bovine surfactant in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1995;152:1050–4.
Griese M, Essl R, Schmidt R, et al.; BEAT Study Group. Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis. Am J Respir Crit Care Med 2004;170:1000–5.
Griese M, Felber J, Reiter K, et al. Airway inflammation in children with tracheostomy. Pediatr Pulmonol 2004;37:356–61.
Paschen C, Reiter K, Stanzel F, Teschler H, Griese M. Therapeutic lung lavages in children and adults. Respir Res 2005;6:138.
Brasch F, Birzele J, Ochs M, et al. Surfactant proteins in pulmonary alveolar proteinosis in adults. Eur Respir J 2004;24:426–35.
Doan ML, Elidemir O, Dishop MK, et al. Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism. Thorax 2009;64:677–81.
Rice A, Tran-Dang MA, Bush A, Nicholson AG. Diffuse lung disease in infancy and childhood: expanding the chILD classification. Histopathology 2013;63:743–55.
Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999;13:1455–76.
Brasch F, Schimanski S, Mühlfeld C, et al. Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency. Am J Respir Crit Care Med 2006;174:571–80.
Thorwarth A, Schnittert-Hübener S, Schrumpf P, et al. Comprehensive genotyping and clinical characterisation reveal 27 novel NKX2-1 mutations and expand the phenotypic spectrum. J Med Genet 2014;51:375–87.
Acknowledgements
We thank the following external physicians for submitting lavage for surfactant diagnostics: Schwerk/Gappa/Rau (Hannover), Zielen/Schulze/Markus/Gascon/Willasch/Wittekindt/Lieb/Brand (Frankfurt a. Main), Seidenberg/Köster/Hartmann/Mahlert (Oldenburg), Körner-Rettberg/Nüßlein/Teig/Gruber (Bochum), Zimmermann/Leis (Erlangen), Baden/Kumpf (Tübingen), Kopp/Urbanek (Freiburg), Escribano (ESP - Valencia), Riedel/Ahrens (Hamburg), Firnhaber/Singer (Hamburg), Hoppe/Rietschel/Hünseler/Welzing (Köln), Hebestreit/Silwedel/Wölfl/Kunzmann (Würzburg), Schaible (Mannheim), Pross/Kroll/Ocker (Stuttgart), Lau/Varnholt/Krude (Berlin), van Kaam/Slot/von der Thüsen (NL- Amsterdam), Werner (Münster), Kremers/Stengel/Saur/Freihorst (Aalen), Rücker/Saadi/Armbruster (München), Kremens/Hanssler/ Große-Onnebrink (Essen), Barker/Wahn (Berlin), Lange/Kriebel/Boschan (Göttingen), Aschmann/Rollow/Vogelberg (Dresden), Prenzel (Leipzig), Hermon, Weitzdoerfer, Amann (A- Wien), Richter (Hannover), Lange (Bonn), Lentze, Zeidler (Bonn), Luisetti/Campo (I- Pavia), Herterich, Engelhardt (Landshut), Krause (Kiel), Kemen (Hamburg), Ahrens (Darmstadt), Hanff/Manzke (Neubrandenburg), Pöschl/Bögershausen (Heidelberg), Kühr/Bosch (Karlsruhe), Rau (Ravensburg), Störing/Roth (Berlin), Aslanidis (Regensburg), Hampel (Regensburg), Barikbin (Berlin), Hammer (Basel), Briassoulis (G- Heraklion), Poplawska (Ludwigshafen), Hülskamp (Münster), Pickert (Heilbronn), Bürger (Traunstein), Gortner (Homburg), Kopp/Ahrens (Lübeck), Nährlich (Giessen), Hubrich (Datteln), Donato (F- Strassbourg), Pin (F- Grenoble), Schirmer-Zimmermann (Nürnberg), Anani (Nürnberg), Gröbner (A- Linz), Laux (Hamburg), Romano (F- Paris), Mildenberger (Mainz), Lasch (Bremen), Kitz (Frankfurt a. Main), Weckelmann (Wuppertal), Renner (Neuburg/Donau), Schröder (Lüneburg), Fuchs (Ulm), Casaulta (CH- Bern), Schuster (Düsseldorf), Andree (Krefeld), Boelke (Villingen-Schwenningen), Braun (Erfurt), Weis (Koblenz), Reitz (Berlin), Ollerieth (A- Wien), and Rubens (Kaufbeuren).
This article contains parts of the thesis of Elke Lorenz.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary Figure S1 (download TIFF )
(TIFF 1563 kb)
Supplementary Figure S2 (download TIFF )
(TIFF 1338 kb)
Supplementary Figure S3 (download TIFF )
(TIFF 1315 kb)
Supplementary Figure S4 (download TIFF )
(TIFF 2158 kb)
Supplementary Figure S5 (download JPEG )
(JPEG 835 kb)
Supplementary Table S1 (download XLSX )
(XLSX 43 kb)
Supplementary Table S2 to Table S4 (download DOCX )
(DOCX 39 kb)
Rights and permissions
About this article
Cite this article
Griese, M., Lorenz, E., Hengst, M. et al. Surfactant proteins in pediatric interstitial lung disease. Pediatr Res 79, 34–41 (2016). https://doi.org/10.1038/pr.2015.173
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/pr.2015.173
This article is cited by
-
Surfactant replacement therapy: from biological basis to current clinical practice
Pediatric Research (2020)
-
Mutations in the thyroid transcription factor gene NKX2-1 result in decreased expression of SFTPB and SFTPC
Pediatric Research (2018)
